Literature DB >> 7781594

Structure-function relationships in the vitamin D endocrine system.

R Bouillon1, W H Okamura, A W Norman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7781594     DOI： 10.1210/edrv-16-2-200

Source DB:  PubMed          Journal:  Endocr Rev        ISSN： 0163-769X            Impact factor:   19.871


× No keyword cloud information.
  146 in total

1.  Rapid actions of calcitriol and its side chain analogues CB1093 and GS1500 on intracellular calcium levels in skeletal muscle cells: a comparative study.

Authors:  G Vazquez; J Sellés; A R de Boland; R Boland
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

Review 2.  Structure function studies: identification of vitamin D analogs for the ligand-binding domains of important proteins in the vitamin D-endocrine system.

Authors:  A W Norman; F R Silva
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

3.  Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands.

Authors:  G Tocchini-Valentini; N Rochel; J M Wurtz; A Mitschler; D Moras
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

Review 4.  [Update of rheumatology--II. State and prospectives of chemotherapy in chronic arthritis].

Authors:  G Hein; T Eidner; P Oelzner; B Manger
Journal:  Med Klin (Munich)       Date:  1999-10-15

5.  Improved docking, screening and selectivity prediction for small molecule nuclear receptor modulators using conformational ensembles.

Authors:  So-Jung Park; Irina Kufareva; Ruben Abagyan
Journal:  J Comput Aided Mol Des       Date:  2010-05-09       Impact factor: 3.686

6.  Design, synthesis, and biological action of 20R-hydroxyvitamin D3.

Authors:  Yan Lu; Jianjun Chen; Zorica Janjetovic; Phillip Michaels; Edith K Y Tang; Jin Wang; Robert C Tuckey; Andrzej T Slominski; Wei Li; Duane D Miller
Journal:  J Med Chem       Date:  2012-03-20       Impact factor: 7.446

7.  Indications on the use of vitamin D and vitamin D metabolites in clinical phenotypes.

Authors:  M L Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2010-09

Review 8.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

9.  EB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancer.

Authors:  Erin L Milliken; Xiaoxue Zhang; Chris Flask; Jeffrey L Duerk; Paul N MacDonald; Ruth A Keri
Journal:  Cancer Lett       Date:  2005-08-22       Impact factor: 8.679

10.  SIRT1 enzymatically potentiates 1,25-dihydroxyvitamin D3 signaling via vitamin D receptor deacetylation.

Authors:  Marya S Sabir; Zainab Khan; Chengcheng Hu; Michael A Galligan; Christopher M Dussik; Sanchita Mallick; Angelika Dampf Stone; Shane F Batie; Elizabeth T Jacobs; G Kerr Whitfield; Mark R Haussler; Michael C Heck; Peter W Jurutka
Journal:  J Steroid Biochem Mol Biol       Date:  2017-06-19       Impact factor: 4.292
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.